Market Cap

$164.8B

Volume

36.3M

Cash and Equivalents

$1.1B

EBITDA

$10.0B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$33.2B

Profit Margin

60.16%

52 Week High

$34.11

52 Week Low

$25.20

Dividend

5.78%

Price / Book Value

1.88

Price / Earnings

-62.10

Price / Tangible Book Value

-3.93

Enterprise Value

$227.9B

Enterprise Value / EBITDA

19.85

Operating Income

$3.3B

Return on Equity

-2.74%

Return on Assets

0.94

Cash and Short Term Investments

$7.1B

Debt

$69.9B

Equity

$88.0B

Revenue

$55.2B

Unlevered FCF

$5.3B

Sector

Pharmaceuticals

Category

N/A